Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Cancer Research|April 19, 2005
Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-rasMarie Wislez, M Loreto Spencer, Julie G Izzo, et al.Gynecologic Oncology|September 13, 2005
Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trialHeung Gon Kim, Jose-Miguel Yamal, Xiao-Chun Xu, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinomaVincent Grégoire, K Kian Ang, Jean-François Rosier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinomaJulie G Izzo, Tsung-Teh Wu, Xifeng Wu, et al.Seminars in Oncology|April 24, 2007
Molecular mechanisms in Barrett's metaplasia and its progressionJulie G Izzo, Rajyalakshmi Luthra, Tseung-Teh Wu, et al.BMC Cancer|August 19, 2011
Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2Khalid A Mohamedali, Sophia Ran, Candelaria Gomez-Manzano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasiaS Eva Singletary, Edward N Atkinson, Ashraful Hoque, et al.Haematologica|February 8, 2020
Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphomaAloke Sarkar, Christine M Stellrecht, Hima V Vangapandu, et al.Molecular Cancer Therapeutics|November 24, 2006
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinomaJulie G Izzo, Arlene M Correa, Tsung-Teh Wu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2006
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinomaJulie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.Pageof 7